Canton Hathaway’s ResMed RMD Stock Holding History

Canton Hathaway’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,200	Closed	-$718K	–	295
2026 Q1	$718K	Hold	3,200	–	–	0.14%	74
2025 Q4	$771K	Hold	3,200	–	–	0.15%	70
2025 Q3	$876K	Hold	3,200	–	–	0.17%	68
2025 Q2	$826K	Hold	3,200	–	–	0.17%	66
2025 Q1	$716K	Buy	+3,200	New	+$747K	0.14%	67

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Canton Hathaway's RMD Position: Q2 2026 in Review

Canton Hathaway sold out of ResMed (RMD) in Q2 2026, closing a stake of 3,200 shares — an estimated $718K sold.

Canton Hathaway first reported a position in RMD in Q1 2025 and held it in 5 quarters. The position peaked at $876K in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Canton Hathaway reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Canton Hathaway sold 3,200 ResMed shares in Q2 2026, an estimated $718K.
Canton Hathaway first reported a position in ResMed in Q1 2025 and held it in 5 quarters.
Canton Hathaway's ResMed position peaked at $876K in Q3 2025.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.